Lung cancer
  • Featured content
    Watch this on-demand Webcast from the CCO non-small-cell lung cancer VA live meeting series where Jonathan Dowell, MD, provides expert perspective on the optimal treatment of patients with advanced NSCLC, including discussion of the most recent clinical data and management of treatment-related adverse events.
  • Featured content
    In this archived Webcast from the 2017 CCO NSCLC nurses chapter meeting series, Gail Kwarciany, MSN, RN-BC, OCN, AOCNS, provides expert perspective on optimal nursing strategies for patients with non-small-cell lung cancer.
  • Featured content
    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
  • Featured content
    Rova-T achieved high response rates in a phase I clinical trial of patients with recurrent SCLC, particularly those with high DLL3 expression. Here’s my take on the promise of Rova T in this patient population.
    Date Posted: 11/3/2017
  • Featured content
    In this text module and accompanying downloadable slideset, experts review key study results presented at the 2017 ESMO annual meeting across multiple malignancies including advanced NSCLC, breast cancer, bladder cancer, renal cell carcinoma, gastric/gastroesophageal cancer, HNSCC, and hepatocellular carcinoma.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 220 Shown
10 of 220 Shown
Show 10 More
Loading...